3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia

Introduction: 3,4‐diaminopyridine has been used to treat Lambert‐Eaton myasthenia (LEM) for 30 years despite the lack of conclusive evidence of efficacy. Methods: We conducted a randomized double‐blind placebo‐controlled withdrawal study in patients with LEM who had been on stable regimens of 3,4‐di...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Muscle Nerve
Main Authors: Sanders, Donald B., Juel, Vern C., Harati, Yadollah, Smith, A. Gordon, Peltier, Amanda C., Marburger, Tessa, Lou, Jau‐Shin, Pascuzzi, Robert M., Richman, David P., Xie, Tai, Demmel, Valentin, Jacobus, Laura R., Aleš, Kathy L., Jacobus, David P.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5900968/
https://ncbi.nlm.nih.gov/pubmed/29280483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.26052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados